Federal Agency · National Institutes of Health
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
Posted November 22, 2024
Funding
Funding amount not specified
Closes
January 7, 2028
NAICS
541714
The purpose of this Notice of Funding Opportunity (NOFO) is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders (e.g., perimenopausal depression (PMD), generalized anxiety disorder, bipolar disorder and schizophrenia) during the menopause transition (MT) in an effort to identity targets for future development of novel treatment interventions.
Eligibility
Funded by NIH and Programs related to transit.
Award details
Applications close on January 7, 2028 (619 days remaining).
Categories
Not categorized
Sign up at GrantRegister to see if this grant matches your organization.
Match my organization →View application on Grants.gov →·Source: Grants.gov·Last seen Apr 28, 2026